首页> 外国专利> NOVEL BIOMARKER FOR BILIARY TRACT CANCER, BASED ON THE CHARACTERISTIC OF BILIARY TRACT CANCER STEM CELLS

NOVEL BIOMARKER FOR BILIARY TRACT CANCER, BASED ON THE CHARACTERISTIC OF BILIARY TRACT CANCER STEM CELLS

机译:基于胆道癌干细胞特征的新型胆道癌生物标志物

摘要

PURPOSE: A method for screening a material which prevents or treats biliary tract cancer using a novel molecular marker is provided to screen a therapeutic agent candidate which is specific to biliary tract cancer stem cells or cancer stem cells.;CONSTITUTION: A method for screening a material which prevents or treats biliary cancer comprises: a step of contacting a sample with a cell or a tissue containing a protein of sequence number 1 or 3 or a polynucleotide of sequence number 2 or 4; and a step of measuring expression level of the protein or polynucleotide. The protein exists on the cell surface, viral surface, or in an isolated form. A kit for detecting biliary cancer stem cells contains a primer or a probe which specifically binds to the protein or polynucleotide.;COPYRIGHT KIPO 2013;[Reference numerals] (AA) Expressing TAGLN2 at normal biliary epithalial tissue and biliary cancer tissue
机译:目的:提供一种使用新型分子标记物筛选预防或治疗胆道癌的材料的方法,以筛选对胆道癌干细胞或癌干细胞具有特异性的治疗剂候选物。预防或治疗胆道癌的材料包括:使样品与含有序列号1或3的蛋白质或序列号2或4的多核苷酸的细胞或组织接触的步骤;和测量蛋白质或多核苷酸表达水平的步骤。该蛋白质以细胞表面,病毒表面或分离形式存在。用于检测胆道癌干细胞的试剂盒包含与该蛋白或多核苷酸特异性结合的引物或探针。; COPYRIGHT KIPO 2013; [参考数字](AA)在正常胆道上皮组织和胆道癌组织中表达TAGLN2

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号